Health Outcomes of Gastric Bypass Patients Compared to Nonsurgical, Nonintervened Severely Obese
Open Access
- 1 January 2010
- Vol. 18 (1), 121-130
- https://doi.org/10.1038/oby.2009.178
Abstract
Favorable health outcomes at 2 years postbariatric surgery have been reported. With exception of the Swedish Obesity Subjects (SOS) study, these studies have been surgical case series, comparison of ...Keywords
This publication has 73 references indexed in Scilit:
- Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgeryContemporary Clinical Trials, 2005
- Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR MutantsPLoS Medicine, 2005
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Flaws in methods of evidence-based medicine may adversely affect public health directivesSurgery, 2005
- National trends in utilization and outcomes of bariatric surgerySurgical Endoscopy, 2005
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLoS Medicine, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004